Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
From MaRDI portal
(Redirected from Publication:6652603)
Cites work
- A general interactive framework for false discovery rate control under structural constraints
- A general statistical framework for subgroup identification and comparative treatment scoring
- A multiplicative structural nested mean model for zero-inflated outcomes
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data
- A robust method for estimating optimal treatment regimes
- A simple method for estimating interactions between a treatment and a large number of covariates
- A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint
- Assessing the heterogeneity of treatment effects via potential outcomes of individual patients
- Assessing the treatment effect heterogeneity with a latent variable
- Bagging predictors
- Bayesian inference for causal effects: The role of randomization
- Bayesian regression tree models for causal inference: regularization, confounding, and heterogeneous effects (with discussion)
- CAPITAL: optimal subgroup identification via constrained policy tree search
- Causal interaction trees: Finding subgroups with heterogeneous treatment effects in observational data
- Comment on ``Dynamic treatment regimes: technical challenges and applications
- Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials
- Confidence intervals for low dimensional parameters in high dimensional linear models
- Confidence intervals for the means of the selected populations
- Correct and logical inference on efficacy in subgroups and their mixture for binary outcomes
- D-learning to estimate optimal individual treatment rules
- Debiased Inference on Treatment Effect in a High-Dimensional Model
- Decomposing Treatment Effect Variation
- Double/debiased machine learning for treatment and structural parameters
- Dynamic treatment regimes. Statistical methods for precision medicine
- Effectively Selecting a Target Population for a Future Comparative Study
- Efficient screening of predictive biomarkers for individual treatment selection
- Efficient Targeted Learning of Heterogeneous Treatment Effects for Multiple Subgroups
- Estimating heterogeneous treatment effects for latent subgroups in observational studies
- Estimating heterogeneous treatment effects with right-censored data via causal survival forests
- Estimating individual treatment effects by gradient boosting trees
- Estimating individualized treatment rules using outcome weighted learning
- Estimating optimal treatment regimes from a classification perspective
- Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
- Estimating treatment effect heterogeneity in randomized program evaluation
- Estimation and accuracy after model selection
- Estimation and Inference of Heterogeneous Treatment Effects using Random Forests
- Estimation in optimal treatment regimes based on mean residual lifetimes with right-censored data
- Estimation of Conditional Average Treatment Effects With High-Dimensional Data
- Estimation of optimal individualized treatment rules using a covariate-specific treatment effect curve with high-dimensional covariates
- Exact post-selection inference, with application to the Lasso
- Exact simultaneous confidence intervals for logical selection of a biomarker cut‐point
- Experimental Evaluation of Individualized Treatment Rules
- Exploratory subgroup analysis in clinical trials by model selection
- Fairness-Oriented Learning for Optimal Individualized Treatment Rules
- False discovery rate control for effect modification in observational studies
- Finding the best subgroup with differential treatment effect with multiple outcomes
- Generalized random forests
- High-dimensional inference: confidence intervals, \(p\)-values and R-software \texttt{hdi}
- scientific article; zbMATH DE number 6378123 (Why is no real title available?)
- scientific article; zbMATH DE number 6276204 (Why is no real title available?)
- Identification and inference for subgroups with differential treatment efficacy from randomized controlled trials with survival outcomes through multiple testing
- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- Inference for optimal dynamic treatment regimes using an adaptive m-out-of-n bootstrap scheme
- Inference for subgroup analysis with a structured logistic-normal mixture model
- Inference on Selected Subgroups in Clinical Trials
- Inference on tree-structured subgroups with subgroup size and subgroup effect relationship in clinical trials
- Learning and confirming a class of treatment responders in clinical trials
- Learning optimal personalized treatment rules in consideration of benefit and risk: with an application to treating type 2 diabetes patients with insulin therapies
- Marginal Mean Models for Dynamic Regimes
- Model-based recursive partitioning for subgroup analyses
- Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes
- Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes
- Multicategory angle-based large-margin classification
- Multicategory outcome weighted margin-based learning for estimating individualized treatment rules
- Multithreshold change plane model: estimation theory and applications in subgroup identification
- On asymptotically optimal confidence regions and tests for high-dimensional models
- On semiparametric instrumental variable estimation of average treatment effects through data fusion
- Optimal Dynamic Treatment Regimes
- Optimal subgroup selection
- Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective
- Performance guarantees for individualized treatment rules
- Personalize treatment for longitudinal data using unspecified random-effects model
- Policy learning with observational data
- Post-selection inference for _1-penalized likelihood models
- Predictive signature development based on maximizing the area between receiver operating characteristic curves
- PRIM analysis
- Quasi-oracle estimation of heterogeneous treatment effects
- Random survival forests
- Randomization inference for treatment effect variation
- Recursive partitioning for heterogeneous causal effects
- Reflections on the concept of optimality of single decision point treatment regimes
- Regularized outcome weighted subgroup identification for differential treatment effects
- Rejoinder of ``Dynamic treatment regimes: technical challenges and applications
- Responder identification in clinical trials with censored data
- Risk controlled decision trees and random forests for precision medicine
- Robust inference of conditional average treatment effects using dimension reduction
- Root-N-Consistent Semiparametric Regression
- Selective Inference for Effect Modification Via the Lasso
- Stability selection. With discussion and authors' reply
- Stabilized direct learning for efficient estimation of individualized treatment rules
- Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy
- Strong control of the familywise error rate in observational studies that discover effect modification by exploratory methods
- Subgroup causal effect identification and estimation via matching tree
- Subgroup selection in adaptive signature designs of confirmatory clinical trials
- Subgroups from regression trees with adjustment for prognostic effects and postselection inference
- Super Learner
- Targeted learning ensembles for optimal individualized treatment rules with time-to-event outcomes
- Targeted optimal treatment regime learning using summary statistics
- The central role of the propensity score in observational studies for causal effects
- The optimal dynamic treatment rule superlearner: considerations, performance, and application to criminal justice interventions
- Towards optimal doubly robust estimation of heterogeneous causal effects
- Transfer Learning of Individualized Treatment Rules from Experimental to Real-World Data
- Tree-based methods for individualized treatment regimes
- Tree-based reinforcement learning for estimating optimal dynamic treatment regimes
- Unit–Treatment Interaction and Its Practical Consequences
- Using decision lists to construct interpretable and parsimonious treatment regimes
- Using knockoffs for controlled predictive biomarker identification
- Who should be treated? Empirical welfare maximization methods for treatment choice
Cited in
(4)- Comparing methods to assess treatment effect heterogeneity in general parametric regression models
- Overview and practical recommendations on using Shapley values for identifying predictive biomarkers via CATE modeling
- Using individualized treatment effects to assess treatment effect heterogeneity
- Explaining individualized treatment rules: integrating LIME and SHAP with XGBoost in precision medicine
This page was built for publication: Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6652603)
